Tazocin (4 gm+0.5 gm)/vial (IV Infusion)

4.5 gm vial: ৳ 1,800.00

Medicine Details

Category Details
Generic Piperacillin tazobactam
Company Pfizer

Indications

  • Intra-abdominal Infections
  • Skin and Skin Structure Infections
  • Female Pelvic Infections
  • Community-acquired pneumonia
  • Nosocomial pneumonia

Pharmacology

  • Bactericidal activity against gram-positive and gram-negative bacteria
  • Inhibition of septum and cell wall synthesis
  • Enhancement and extension of antibiotic spectrum

Dosage & Administration

  • Administered by intravenous infusion
  • Usual total daily dose for adults
  • Recommended duration of treatment for nosocomial pneumonia
  • Dosage for pediatric patients

Interaction

  • Inactivation of aminoglycosides
  • Sequential administration with tobramycin
  • Effect on probenecid, anticoagulants, vecuronium, and methotrexate

Contraindications

  • History of allergic reactions to penicillins, cephalosporins, or beta-lactamase inhibitors

Side Effects

  • Adverse events primarily involving the skin, gastrointestinal system, general disorders, immune hypersensitivity reactions, infections, metabolism, musculoskeletal and connective tissue, psychiatric disorders, vascular disorders, hypotension, and respiratory disorders

Pregnancy & Lactation

  • Crosses the placenta
  • Insufficient data on drug-associated risk for major birth defects and miscarriage
  • Excreted in human milk

Precautions & Warnings

  • Serious hypersensitivity reactions
  • Severe cutaneous adverse reactions
  • Hematological effects
  • Nephrotoxicity in critically ill patients
  • Clostridium difficile associated diarrhea

Use in Special Populations

  • Pediatric use
  • Geriatric use
  • Renal impairment
  • Hepatic impairment
  • Patients with cystic fibrosis

Overdose Effects

  • Nausea, vomiting, and diarrhea
  • Neuromuscular excitability or convulsions
  • Supportive and symptomatic treatment

Therapeutic Class

  • Broad spectrum penicillins
  • Other beta-lactam Antibiotics

Reconstitution

  • Administration by intravenous infusion over 30 minutes
  • Withdrawal and mixing of diluent
  • Immediate usage after reconstitution
  • Storage conditions for reconstituted vials

Storage Conditions

  • Keep below 30°C temperature
  • Away from light and moisture

Related Brands